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Abstract
Notch signaling is central to vertebrate development, and analysis of Notch has provided important
insights into pathogenetic mechanisms in the CNS and many other tissues. However, surprisingly
little is known about the role of Notch in the development and pathology of Schwann cells and
peripheral nerves. Using transgenic mice and cell cultures, we found that Notch has complex and
extensive regulatory functions in Schwann cells. Notch promoted the generation of Schwann cells
from Schwann cell precursors and regulated the size of the Schwann cell pool by controlling
proliferation. Notch inhibited myelination, establishing that myelination is subject to negative
transcriptional regulation that opposes forward drives such as Krox20. Notably, in the adult, Notch
dysregulation resulted in demyelination; this finding identifies a signaling pathway that induces
myelin breakdown in vivo. These findings are relevant for understanding the molecular mechanisms
that control Schwann cell plasticity and underlie nerve pathology, including demyelinating
neuropathies and tumorigenesis.
Schwann cells associate with axons in peripheral nerve trunks. They control neuronal survival
in the embryo, provide myelin that is essential for normal movement and sensation in the adult,
and control regeneration and repair in injured nerves1–3.
Notch signaling is integral to the development of the main types of glial cell in the CNS,
including astrocytes, Müller cells, radial glia and oligodendrocytes4,5, and Notch dysfunction
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has been implicated in a range of CNS diseases, including tumorigenesis and
neurodegeneration6,7. In view of this, it has become important to understand the role of Notch
in the development and pathology of Schwann cells, a system in which the involvement of
Notch is surprisingly poorly understood.
Here, we describe the role of Notch in the generation and amplification of Schwann cells in
embryonic nerves; in myelination in perinatal nerves; and in the dramatic response of Schwann
cells to injury in adult nerves.
For these studies we generated several mouse mutants with conditional activation or
inactivation of Notch signaling at different stages of the Schwann cell lineage (see
Supplementary Fig. 1 online for the Notch pathway and our strategy). We focused on limb
nerves in which the key transitions of the lineage have been unambiguously established
(Supplementary Fig. 2 online)1. First, Schwann cell precursors (SCPs), which occupy mouse
limb nerves at embryo day (E) 12/13 (E14/15 in the rat), are formed from neural crest cells.
Second, immature Schwann cells, which occupy nerves from E15/16 (E17/18 in the rat), are
generated. At this stage, axon/Schwann cell numbers are matched by regulation of Schwann
cell proliferation and death. Third, immature cells diverge to form myelinating and non-
myelinating cells. Before myelination, which starts around birth, axons and promyelin
Schwann cells establish a 1:1 relationship from the irregular groups of axons and Schwann
cells (Schwann cell families) that characterize embryonic nerves. This process is known as
radial sorting2. Remarkably, in injured adult nerves, mature Schwann cells can dedifferentiate
to a phenotype related to that of the immature Schwann cell8–10.
We find that in embryonic nerves Notch accelerates the generation of Schwann cells from SCPs
and regulates the size of the Schwann cell pool by controlling proliferation, without affecting
apoptosis. In perinatal nerves, Notch acts as a brake to delay myelination, without affecting
radial sorting. This finding establishes in vivo that myelination is subject to negative
transcriptional regulation that opposes forward drivers of the process such as the key myelin
transcription factor Krox20. Significantly, in adult nerves, Notch dysregulation results in
demyelination. This represents, to the best of our knowledge, the first identification of a
signaling pathway that induces myelin breakdown in vivo. These data establish that Notch
regulates every developmental step of the Schwann cell lineage and controls pathological
conditions in adult nerves.
RESULTS
Notch signaling and gliogenesis
Notch signaling in Schwann cells has mainly been studied in the context of initial gliogenesis
from the neural crest or from crest-like cells2. Even here, the role of Notch remains unclear,
as Notch activation in cultured crest cells promotes glial differentiation in rat11, but not
chick12, whereas Notch activation in the neural crest in ovo fails to promote the generation of
Schwann cells13.
When we examined spinal nerves in mouse embryos lacking Hes 1 and/or Hes 5, the effectors
of canonical Notch signaling14, we found no significant effect on SCP formation (Fig. 1a and
Supplementary Table 1 online). Consistent with this, Schwann cell generation is reported to
occur in mice with neural crest-selective ablation of RBPJ15, the key transcriptional mediator
of canonical Notch signaling14, although the development of satellite cells and ganglia is
impaired.
In vitro, we failed to induce expression of the early glial (SCP) marker protein zero (P0) by
infecting crest cells with an adenovirus expressing NICD, the active intracellular portion of
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the Notch receptor14 (Ad-NICD). In parallel experiments, P0 was readily induced by the
gliogenic signal retinoic acid (Fig. 1b). These experiments indicate that the first step in the
generation of Schwann cells, namely the appearance of SCPs, does not depend on canonical
Notch signals.
Notch pathway components in the Schwann cell lineage
To determine the potential importance of the Notch pathway in the rest of the Schwann cell
lineage, we showed that its components are expressed in rat sciatic nerves at different ages
(Fig. 2a,b). Immunolabeling of teased nerves and freshly dissociated cells confirmed that the
Notch ligand Jagged 1 was expressed by axons and glia, whereas Notch 1 was detected only
on glial cells (Fig. 2c).
Notch receptors in developing Schwann cells could therefore be activated by Notch ligands on
axons or on the glial cells themselves. The finding that these nerves contain high levels of
NICD (Fig. 2d) is also consistent with active Notch signaling in embryonic and early postnatal
nerves.
Notch drives differentiation of Schwann cell precursors
We next investigated whether Notch controlled the differentiation of SCPs to Schwann cells
by examining three changes that mark this transition: downregulation of the transcription factor
AP2α, upregulation of S100β protein and upregulation of the lipid antigen O41,2, using loss-
of-function and gain-of-function experiments in vivo.
Using Dhh-cre+ mice (Supplementary Figs. 1 and 2), we found that Notch inactivation in SCPs,
by conditional deletion of RBPJ, delayed both AP2α downregulation and S100β upregulation.
This was evident from the intensity of immunolabeling and the number of labeled cells in nerve
sections (24% increase in AP2α+ cells and 30% decrease in S100β+ cells). We saw a similar
delay (40%) in O4 appearance when E14 nerves were dissociated and immunolabeled (Fig.
3a). Similar results were obtained when Notch 1 was deleted in SCPs (Supplementary Table 2
online). This indicates that, in normal nerves, canonical (RBPJ-dependent) Notch signaling
drives Schwann cell generation.
To show this directly, we generated a mutant with activated Notch in SCPs by breeding Dhh-
cre+ mice with CALSL-NICD mice (Supplementary Figs. 1 and 2). We found the opposite
effect of that seen after Notch inactivation. Downregulation of AP2α and upregulation of
S100β were both accelerated (28% decrease in AP2α+ cells and 35% increase in S100β+ cells).
The number of O4+ cells increased by 46% (Fig. 3b). Therefore NICD activation in SCPs
results in premature Schwann cell generation.
This effect of Notch does not depend on other factors that are selectively present in vivo,
because we found that Notch activation strongly promoted the transition from SCPs to Schwann
cells in vitro as judged by two independent criteria, the appearance of the Schwann cell marker
GFAP16 and autocrine survival mechanisms17 (Fig. 3c–e). Thus, canonical Notch signaling
drives the second step in the generation of Schwann cells from neural crest cells, namely the
transition from SCPs to immature Schwann cells.
Notch elevates erbB2 receptors and responsiveness to NRG1
We have shown previously that the transition from SCPs to immature Schwann cells in vitro
is also promoted by neuregulin-1 (NRG1)18. We therefore sought a link between Notch and
NRG1 signaling, as seen in the development of radial glia4,5. We found that Notch activation
in SCPs selectively upregulated the ErbB2 receptors for NRG1 and increased the sensitivity
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of SCPs to NRG1. This was measured using an NRG1-dependent SCP survival assay19 (Fig.
3f,g).
These results point towards a mechanism by which Notch promotes Schwann cell generation
in vivo, namely by maintaining high levels of ErbB2 receptors in SCPs, leading to enhanced
NRG1 signaling, which is required for SCP survival and is probably involved in promoting
lineage progression2,19,20. In support of this idea, we found that inactivation of Notch signaling
in SCPs in vivo resulted in a sharp fall in ErbB2 protein in E14 nerves (Fig. 3h).
Notch controls Schwann cell proliferation and numbers
Schwann cell generation from SCPs occurs during a period of increasing cell proliferation2,
21,22 that peaks at the immature Schwann cell stage, a time of maximal NICD expression (Fig.
2d), indicating that Notch might drive Schwann cell proliferation. When we conditionally
deleted RBPJ or Notch 1 using P0-cre+ mice (Supplementary Figs. 1 and 2), we found a marked
reduction in proliferation (incorporation of 5-bromodeoxyuridine (BrdU) and phosphohistone
(PH3) labeling) in both mouse lines (Fig. 4a–c and Supplementary Table 3 online).
To confirm this, we examined proliferation in mice with activated NICD in Schwann cells
(P0-cre+ mice bred with CALSL-NICD mice; Supplementary Figs. 1 and 2). Even though cells
in control nerves proliferated rapidly, both BrdU incorporation and PH3 labeling were
significantly increased in this mutant (Fig. 4d,e and Supplementary Table 3).
When we counted Schwann cell nuclei in ultra-thin sections of P2 nerves, we found that in all
three mutants Schwann cell numbers changed in line with expectations. There was a reduction
of 30% and 18% in P0cre+RBPJf/f mice and P0cre+Notch1f/f mice, respectively, and an increase
of 13% in P0cre+CALSL-NICD mice (Fig. 4c,f and Supplementary Table 3). These findings
indicate that the canonical Notch pathway is mitogenic for Schwann cells and that NICD
elevation is part of the mechanism that controls proliferation and numbers in developing nerves.
To show this directly, we examined proliferation in immunopurified cultured Schwann cells
after Notch activation. We found that BrdU incorporation was strongly stimulated by either
infection with Ad-NICD (Fig. 4g) or co-culture with the immortalized cell line 3T3, expressing
the Notch ligand, Delta 1 (data not shown).
To confirm that Notch stimulates proliferation, we used cells that lack RBPJ (RBPJnull;
RBPJf/f cells treated in vitro with Cre adenovirus). Ad-NICD did not induce DNA synthesis in
these cells, unlike NRG1 (Fig. 4h,i). The reduced proliferation observed in vivo in mice that
lack RBPJ (P0-cre+RBPJf/f mice) therefore reflects reduced Notch, but not NRG1, signaling.
Enforced NICD expression also upregulated the cell cycle markers cyclin D1 and cdk2 (Fig.
4j). The mitogenic effect of NICD on Schwann cells involved and depended on phosphorylation
of the kinases ERK1/2 and JNK, but not p38 kinase (Fig. 4k,l). Apoptotic cell death2,23
(measured by TdT-mediated dUTP nick end (TUNEL) labeling) was unaffected in E17 nerves
of the three Notch mutants (Supplementary Fig. 3 online). In embryonic nerves, therefore,
Notch signaling controls Schwann cell proliferation and numbers, but not apoptotic cell death.
Krox20 suppresses Notch signaling in myelinating cells
We next investigated Notch signaling in perinatal nerves during myelination. This process,
which starts around birth, is incompatible with proliferation, and most Schwann cells have
stopped dividing as they reach the pro-myelin 1:1 stage and start significant myelin gene
activation2,21,24.
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Using fluorescence activated cell sorting (FACS) to separate myelinating cells from cells that
are not making myelin in P5 nerves, we found that Notch signaling (which drives proliferation)
is inactivated in myelinating cells in vivo (Fig. 5a). This is consistent with the downregulation
of NICD protein at the start of myelination in postnatal nerves (Fig. 2d).
The transcription factor Krox20 activates myelin genes and suppresses genes associated with
immature Schwann cells1,25–27. We found that Krox20 suppressed Notch signaling in
myelinating cells, as in culture, enforced Krox20 expression by adenoviral infection (Ad-K20)
suppressed NICD protein, and in vivo, NICD levels remained high in P7 Krox20–/– animals,
but low in normal nerves (Fig. 5b,c).
Enforced Krox20 expression also suppressed exogenous NICD in Schwann cells (after stable
infection with a retrovirus encoding NICD) showing that Krox20 can reduce NICD protein
post-translationally (Fig. 5d). This depended on the ubiquitin-proteasomal degradation
pathway (Fig. 5e). As expected, because Krox20 suppresses NICD post-translationally, the
enhanced NICD levels in P0-cre+CALSL-NICD nerves (Supplementary Fig. 2) declined
postnatally, when Krox20 was activated upon myelination (Fig. 5f).
Notch signaling times the onset of myelination
Because Notch drives proliferation and is downregulated in myelinating cells, we tested
whether Notch inhibits myelination. In vitro, upregulation of the myelin proteins periaxin and
P0 by enforced Krox20 expression was inhibited by simultaneous infection with Ad-NICD
(Supplementary Fig. 4 online). The inhibition was transient, as expected, because Krox20
eventually suppresses exogenous NICD expression (Fig. 5d). Enforced NICD expression also
blocked cAMP-induced upregulation of myelin proteins28,29 (Supplementary Fig. 4), and
myelination in neurone-Schwann cell co-cultures27 (Supplementary Fig. 5 online). Notch
therefore negatively regulates myelination in vitro.
To determine whether Notch is part of the mechanism that times the onset of myelination in
vivo, we examined nerves from P0-cre+CALSL-NICD mice, in which NICD levels are
transiently elevated (Fig. 5f). We counted the number of myelin sheaths in each nerve profile
in P2 nerves, and divided this by the number of Schwann cell nuclei (because NICD affects
cell numbers), to obtain a normalized number of myelin sheaths (NNMS). This was reduced
from 2.3 in controls to 1.4 in mutants (n = 10, P < 0.01; Fig. 5g and Supplementary Table 4
online). We measured myelin thickness in P5 nerves, and found that mutant nerves contained
significantly more Schwann cells with thin myelin and fewer Schwann cells with thick myelin
than controls (Fig. 5h and Supplementary Table 4). Both measures therefore revealed a
significant reduction in myelination in the mutants. P2 mutant nerves also contained less P0
protein (Supplementary Fig. 5). Adult mutant nerves, however, had normal g-ratios (axon
diameter to fiber diameter), axon diameters and numbers of myelinated axons, reflecting the
transient NICD elevation in perinatal nerves (Supplementary Fig. 6 online).
To confirm that Notch inhibits myelination independently of proliferation, we selectively
examined Schwann cells that had already segregated from the Schwann cell families found in
developing nerves and formed a 1:1 relationship with axons (pro–myelin cells plus myelinating
cells), because proliferation has essentially ceased in these cells2,21,24. Within this population,
we found a substantial (30%) reduction in the number of myelinating cells, and a corresponding
increase in pro-myelin cells (Supplementary Table 4). This is the expected outcome if NICD
inhibits myelination, that is, the transition of pro-myelin cells to myelinating cells.
We compared this inhibitory effect of NICD in two genetic backgrounds: normal Krox20+/+
and Krox20+/– mice. Again examining the segregated cells only, we found that the NICD-
induced reduction in myelinating cells seen in the normal background (Krox20+/+ mice) was
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more pronounced in Krox20+/– mice; myelin sheaths were also substantially thinner (Fig. 5i,j).
There was no difference in myelination between Krox20+/+ and Krox20+/– control nerves.
Thus, myelination defects in P0-cre+CALSL-NICD mice were amplified on a Krox20+/–
background.
Because Notch activation delays myelination, we tested whether, conversely, Notch
inactivation in vivo would accelerate it. In P0-cre+Notch1f/f mice, where Notch 1 has been
excised, the myelin sheaths in P5 nerves were significantly thicker than in controls (Fig. 6a
and Supplementary Table 5 online). In P2 nerves, there was also a 40% increase in the NNMS.
Analysis of segregated cells revealed a striking increase (70%) in the ratio of myelinating cells
to pro-myelin cells, confirming that this increase in myelination was independent of
proliferation (Supplementary Table 5). Thus, myelination is substantially accelerated in
Schwann cells that lack Notch 1. These experiments show that Notch is a negative regulator
of myelination and Krox20-dependent downregulation of Notch signaling is obligatory for the
normal onset of myelination.
Notch controls myelination by RBPJ–independent mechanisms
Although RBPJ is an important downstream effector of Notch, in some cases, an elevation in
NICD can signal independently of RBPJ30,31. We found that, by any of our measures, P0-
cre+RBPJf/f mice had normal myelin, in contrast to that seen in mice without Notch 1 (Fig. 6b
and Supplementary Table 6 online). In cultured Schwann cells, Ad-NICD could also suppress
cAMP- and Krox20-induced myelin protein expression, even in the absence of RBPJ (Fig. 6c–
f). Adult nerves from both P0-cre+Notch1f/f and P0-cre+RBPJf/f mice were normal
(Supplementary Fig. 6). Therefore, the negative regulation of myelination by Notch is
independent of RBPJ, in contrast to the positive regulation of Schwann cell generation and
proliferation, which work through the canonical RBPJ-dependent pathway.
Notch drives Schwann cell demyelination in injured nerves
Remarkably, mature myelinating Schwann cells in adult nerves can dedifferentiate and adopt
a phenotype related to that of immature Schwann cells8–10. Because Notch acts as a brake to
delay myelination, we tested whether Notch was also involved in driving demyelination, a key
feature of dedifferentiation. First, we found that infection of P5 Schwann cell cultures with
Ad-NICD accelerated the normal loss of myelin in vitro (Fig. 7a). Second, NICD protein was
strongly upregulated in the distal stump of transected nerves 1 and 2 d after they were cut (Fig.
7b), a prerequisite for functional involvement of Notch in dedifferentiation. Third, in the
absence of RBPJ the rate of demyelination in cut sciatic nerves was substantially reduced. The
number of intact myelin sheaths was 80% higher and the area occupied by MBP+ myelin 70%
greater in nerves lacking RBPJ 3 d after transection (Fig. 7c,d). Similar results were obtained
in mice lacking Notch 1 (Supplementary Fig. 7 online).
In the transected facial nerve, the number of cells in the distal stump that retained expression
of MBP and the myelin transcription factor Krox20 3 d after transection was also significantly
higher in the absence of RBPJ. Furthermore, the number of cells that expressed p75NTR, a
marker of immature and non-myelinating cells1,2, was significantly reduced, indicating
delayed reversal to the immature phenotype (Supplementary Fig. 8 online). These observations
show that without canonical RBPJ-dependent Notch signaling, the rate of Schwann cell
dedifferentiation in cut nerves is reduced.
To show directly that Notch can accelerate demyelination in vivo, we examined myelin
disappearance in cut nerves of P0-cre+CALSL-NICD mice. First, we confirmed that nerve
transection in these mice elevated NICD when compared with cut control nerves (Fig. 7e). This
was expected because nerve injury will trigger expression of both the endogenous NICD (Fig.
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7b) and the CALSL-NICD transgene, both of which are suppressed in intact nerves through a
Krox-20-dependent mechanism (Fig. 5e,f). This increase in NICD resulted in accelerated
dedifferentiation. The P0-cre+CALSL-NICD nerves contained 50% fewer intact myelinating
Schwann cells and the area occupied by MBP+ myelin was 50% smaller than in cut control
nerves 3 d after transection (Fig. 7f,g). These experiments show that Notch signaling drives
demyelination in injured nerves through an RBPJ-dependent mechanism.
Notch initiates demyelination even in uncut nerves
In demyelinating neuropathies, demyelination occurs even though Schwann cells remain in
contact with axons until the later stages when axons die32,33. The results shown in Figure 7
raise the question of whether Notch activation is sufficient to trigger demyelination in cells
that maintain axonal contact. Initially, we addressed this by showing that infection of
established myelinating co-cultures of neurons and Schwann cells with Ad-NICD resulted in
myelin damage and apparent breakdown in a high proportion of infected cells, whereas very
few Ad-GFP-infected cells had disrupted myelin (Fig. 8a).
We obtained the same result in adult nerves in vivo when we injected intact nerves with Ad-
NICD or Ad-GFP. Quantification of demyelination 10 d later showed that Notch activation
induced extensive demyelination, revealed by a sixfold increase in the number of degenerating
myelin sheaths and 90% loss of MBP+ myelin (Fig. 8b,c). These results indicate that tight
control of Notch signaling is essential for the maintenance of myelin integrity.
DISCUSSION
We show that Notch signaling has multiple regulatory functions in Schwann cells that operate
right across the lineage, from the SCPs in early embryonic nerves to the control of responses
to injury in mature cells. Notch stimulates SCP differentiation and accelerates Schwann cell
formation and proliferation in perinatal nerves, inhibits further differentiation and induces
dedifferentiation in the adult. On one hand, therefore, the actions of Notch are strikingly
pleiotropic and context-dependent. On the other hand, these diverse effects work towards one
related biological outcome: the generation of the immature Schwann cell state in development
or its closely related counterpart, the denervated Schwann cell in the adult. The role of Notch
in the plasticity of postnatal Schwann cells indicates that it might be involved in the numerous
Schwann cell disorders that involve dedifferentiation, including tumor formation and
demyelinating neuropathies, and raises the possibility that the Notch pathway is relevant for
the regeneration of damaged nerves.
Schwann cell generation
Rather than instructing gliogenesis from the trunk neural crest, we find that Notch signaling
acts at the second step of Schwann cell development by promoting the formation of immature
Schwann cells from SCPs. SCPs are distinct from migrating neural crest cells because, first,
they express glia-associated genes, including P0, desert hedgehog and BFABP; second, they
differ from crest cells in survival and proliferative responses to extracellular signals; and third,
unlike crest cells, they are always in tight apposition to axons, a universal characteristic of glia
in the PNS and CNS. Global gene expression analysis also shows that a large group of genes
is differentially expressed between SCPs and migratory neural crest cells1,2. Using five
independent criteria in in vivo and culture experiments, we find that Notch inactivation in these
cells retards their differentiation into immature Schwann cells whereas Notch activation
accelerates it.
Our data can be reconciled with the apparent promotion by Notch of Schwann cell generation
from neural crest or crest-like cells, rather than from SCPs, in 14-d assays using the Schwann
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cell marker GFAP11,13. In these experiments, it is plausible that the long period in complex
medium allowed some crest cells to generate SCPs. In such cultures, Notch activation would
lead to the observed increase in Schwann cells by promoting the transition from SCPs to
Schwann cells rather than by acting on neural crest cells, and by stimulating Schwann cell
proliferation.
Indirect support for the importance of Notch at this point in development comes from the fact
that sensitivity to Notch signaling and Notch expression are much higher at the SCP stage than
in migrating crest cells11. Thus, we conclude that Notch regulates Schwann cell generation at
the SCP–Schwann cell transition.
Schwann cell proliferation
Our data establish canonical Notch signaling as an important positive regulator of Schwann
cell proliferation and numbers. The decrease in Schwann cell numbers after Notch inactivation
(P0-cre+RBPJf/f and P0-cre+Notch1f/f mice) was mirrored in a quantitatively similar reduction
(by 38% and 16% respectively, P < 0.05) in the total number of segregated axon–Schwann cell
units (pro-myelinating plus myelinating). This relationship between axonal segregation, and
therefore the number of cells available for myelination, and total cell numbers has not been
demonstrated before to our knowledge.
It follows that the extent of myelination in early nerves is a function of Schwann cell numbers.
Notch is, however, unlikely to be involved in the mechanism of segregation itself, because the
ratio of segregated cells (pro-myelinating and myelinating) to total cells is not significantly
different between Notch-inactivated and control nerves (5.3 ± 0.2 and 5.9 ± 0.3 in P0-
cre+RBPJf/f mice and controls, respectively, and 6.1 ± 0.3 and 6.0 ± 0.4 in P0-cre+Notch1f/f
mice and controls, respectively). Therefore, the probability of an axon segregating does not
vary according to whether Notch signaling is present.
Negative regulation of myelination
Previous experiments have identified a set of positive transcriptional regulators of myelination,
namely Krox20, Sox-10, Oct-6 and Brn2, the inactivation of which delay or prevent
myelination in vivo1,34. The present results establish that the transcriptional regulation of
myelination during development also incorporates a negative regulatory component. We find
that inactivation of Notch 1 promotes in vivo myelination and Notch activation delays it. This
delay is inversely proportional to levels of the key positive regulator Krox20, indicating that
a balance between positive and negative regulatory mechanisms is used to time the onset of
myelination. In oligodendrocytes, Notch also negatively regulates myelination in vitro35 and
reduced levels of Notch 1 result in premature myelination in vivo36. In addition, it has been
proposed that Notch activation in oligodendrocyte precursors inhibits their maturation into
myelinating oligodendrocytes in multiple sclerosis plaques37.
We find no enhanced myelination in nerves lacking RBPJ, in contrast to that seen in nerves
without Notch1. Experiments on individual cells also show that NICD does not require RBPJ
to inhibit the effects of the pro-myelin signals cAMP or Krox20. Together these results reveal
an RPBJ-independent signaling pathway that acts as a brake on myelination. Although Notch
times two key transitions, from SCPs to immature Schwann cells and immature Schwann cells
to myelinating cells, the mechanisms of these two processes are notably different. The first
involves RBPJ-dependent promotion of differentiation, whereasthe second involves RBPJ-
independent inhibition of differentiation.
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Myelin stability and breakdown in cut and normal nerves
After injury to adult nerves, Schwann cells lose their myelin sheaths and dedifferentiate to a
phenotype related to that of immature Schwann cells8–10. This is accompanied by a sharp
increase in NICD. The Notch ligands Jagged 1 and 2 are also upregulated (A.W., R.M. and
K.R.J., unpublished data), but it is not known whether the Schwann cells themselves,
macrophages or other cells activate Notch in Schwann cells under these conditions.
In injured nerves, NICD accelerates myelin breakdown. This is severely retarded in the absence
of either RBPJ or Notch1 and therefore depends on the canonical RBPJ pathway. The finding
that Notch activates different mechanisms to negatively regulate myelination during
development and injury was unexpected. It indicates that, more generally, the molecular
machinery that controls adult Schwann cell plasticity might differ significantly from the
machinery that regulates development.
The present experiments and other recent work indicate that myelin breakdown and other
aspects of Schwann cell dedifferentiation are controlled through the activation of a group of
transcriptional regulators. In addition to Notch, in vivo evidence for this type of function exists
for c-Jun27, and Sox-2, Pax-3 and Id2 might also be involved in Schwann cell
dedifferentiation1,8. We therefore suggest that Schwann cells contain a set of negative
transcriptional regulators that functionally complement the previously established positive
regulatory proteins and that myelination and demyelination are determined by a balance
between two opposing transcriptional programs1,8.
The ability of Notch signaling to shift this balance and to drive myelinating cells towards
demyelination is shown by the observation that activation of NICD in myelinating cells even
of intact, uncut nerves results in severe demyelination. This finding shows that myelin stability
and the maintenance of the myelinated state depend crucially on continuous inhibition of Notch
signaling. It will be important to determine whether enhanced Notch signaling is a component
of the pathogenetic mechanisms in inherited or acquired demyelinating neuropathies. In
addition, the fact that Notch is mitogenic in Schwann cells raises the question of whether
aberrant Notch activation could lead to the formation of Schwann cell tumors. In support of
this idea, Notch can induce transformation in long-term cultured rat Schwann cells that can
generate tumors when injected into nude rats38 and Notch acts as an oncogene in a number of
cancers, including brain tumors6.
METHODS
Methods and any associated references are available in the online version of the paper at
http://www.nature.com/natureneuroscience/.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Notch signaling is not involved in the generation of SCPs from neural crest cells. (a) Disruption
of canonical Notch signaling does not impair gliogenesis in spinal nerves. Both control and
mutant embryos express the SCP marker BFABP1,2 (red) in embryonic nerves (arrowheads)
in E11 Hes1–/– and Hes5–/–, and E10 Hes1–/– Hes5–/– mice. The neural tube is disorganized in
Hes1–/– Hes5–/– mice39 but BFABP+ cells are still associated with peripheral nerves. Insets:
the sections were double immunolabeled with TUJ1 antibodies that bind to class III β-tubulin
(green) in axons (arrowheads). DRGs (asterisk) are also BFABP+. S, spinal cord. The
percentage of cells (Hoechst+ nuclei) in ventral roots or spinal nerves that express BFABP was
not statistically different between control and mutant embryos (quantification: Supplementary
Table 1). (b) Notch activation in rat neural crest cells (NCCs) does not upregulate the SCP
marker P0. NCCs (1 d after emigration from neural tube) do not express P0 mRNA or protein,
whereas freshly isolated SCPs express both. Culture of NCCs in retinoic acid (100 ng ml–1)
for 3 d (NCC + RA) upregulates P0 mRNA and protein, reflecting in vitro gliogenesis. Notch
activation in NCCs, by adenoviral infection (NCC + Ad-NICD), does not upregulate P0 mRNA
or protein after 3 d.
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Figure 2.
Notch signaling pathway molecules are expressed at different stages in the Schwann cell
lineage. (a) PCR of Notch pathway components in rat sciatic nerves at E14 (SCPs), E18
(immature Schwann cells) and P3–15 (active myelination). Notch 1 mRNA increases between
E14 and E18/P3, and decreases afterwards. Notch 2 and Notch 3 mRNA is not detectable at
E14 but found from E18 onwards. Hes1 is high at E14 and at E18 but lower postnatally.
Numb and Numblike mRNAs are low at E14 but detectable from E18 onwards. Gapdh: loading
control. (b) PCR of Notch ligands in rat DRGs. Delta 1 and 3 are expressed only at E15, whereas
Jagged 1 and 2 are expressed at E15 and birth but decrease thereafter. Gapdh: loading control.
(c) Expression of Notch 1 and Jagged 1 in E14 and at birth (NB) teased sciatic nerves, and in
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SCP and Schwann cell cultures. Notch 1 (green) is expressed by SCP and Schwann cells
(arrowheads) but is absent from axons in teased nerves (arrows), identified by neurofilament
(NF; red). Jagged 1 (green) is seen on axons (arrows) and by SCP and Schwann cells
(arrowheads). L1 and S100β were used to identify SCP and Schwann cells, respectively, in
dissociated cultures. (d) Western blot of NICD in rat sciatic nerve extracts. NICD increases
between E14 and E18/NB, and decreases from P3 onwards. GAPDH: loading control.
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Figure 3.
Notch drives Schwann cell generation from SCPs. (a,b) Top and middle panels, longitudinal
sections of E14 hind limb nerves immunolabeled for TUJ1 (inset; red), AP2α or S100β (DAB).
Insets, spinal cord (S), DRG (arrowheads). Bottem panels, dissociated cells from E14 sciatic
nerves; 04 immunolabeling. Nuclei (blue): Hoechst dye. In Dhh–cre+RBPJf/f nerves (mutant),
AP2α labeling is increased, while S100β and O4 are decreased (a). In Dhh–cre+CALSL–
NICD nerves (mutant), AP2α labeling is reduced while S100 and 04 are increased (b)
(quantification: Supplementary Table 2). (c) Notch activation in SCPs, by co-culture with
Delta1-expressing 3T3 cells, accelerates their differentiation into Schwann cells, judged by
GFAP expression (red) over a 5-d (D1–5) period. SCPs were 94–99% pure (L1 labeling)1,2.
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Nestin (green) labels SCPs and Schwann cells. (d,e) Infection of SCPs with Ad-NICD
accelerates differentiation into Schwann cells, judged by GFAP expression, 2 (D2) and 4 (D4)
d after infection (d), and appearance of autocrine survival mechanisms at 2 d in cells plated at
high density (10,000 cells; e). (f) Western blot showing that ErbB2 receptors are elevated in
Ad-NICD-infected SCP cultures. Phospho-p38 levels are also elevated. (g) The NRG1
concentration needed for 50% survival of Ad-NICD-infected SCPs is only about half that
needed for control Ad-GFP-infected cells. (h) Western blot showing reduced ErbB2 in mutant
(Mut) E14 sciatic nerves from Dhh-cre+RBPJf/f and Dhh-cre+Notch1f/f mice. Data: mean ±
s.e.m., n = 3, *P < 0.01.
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Figure 4.
Notch signaling controls the proliferation of immature Schwann cells. (a–c) RBPJ inactivation.
(a) E17 nerve sections showing fewer BrdU+ Schwann cells (green) in P0-cre+RBPJf/f nerves.
Hoechst (): nuclei. (b) RBPJ inactivation significantly reduces BrdU+ and PH3+ cells in E17
nerves. (c) The number of Schwann cell (SC) nuclei in P2 nerves is decreased in mutants. (d–
f) Enforced NICD expression. (d) E17 nerve sections showing increased BrdU+ Schwann cells
(green) in P0-cre+CALSL-NICD nerves. (e) NICD significantly increases BrdU+ and PH3+
cells in E17 nerves. (f) The number of Schwann cell nuclei in P2 nerves is increased in mutants.
(g-l) Notch activation in cultured Schwann cells. (g) Ad-NICD-infected Schwann cells have
more BrdU+ cells (red) than controls (73.9 ± 2.0 compared to 4.6 ± 1.3). (h,i) BrdU+ cells in
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control or RBPJnull Schwann cells after infection with Ad-NICD (h), or in the presence of
absence of NRG1 (i), showing that Ad-NICD, unlike NRG1, fails to induce DNA synthesis in
the absence of RBPJ. (j,k) Western blot shows upregulation of cyclin D1 and cdk2 (j) and
phospho-ERK 1/2 and phospho-JNK 1/2 (k), in Ad-NICD-infected Schwann cells 2 d after
infection. NICD demonstrates enforced NICD expression. β-tubulin: loading control. (l) Ad-
NICD-induced proliferation in Schwann cells in vitro is inhibited by JNK peptide (to block
JNK phosphorylation) or UO126 (to block ERK1/2 phosphorylation) but not by SB202190 (to
block p38 kinase phosphorylation). Data: mean ± s.e.m., n = 3, *P < 0.01.
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Figure 5.
Notch signaling inhibits myelination. (a) PCR shows downregulation of Notch1, Notch2 and
Hes1, and upregulation of Jagged1 and Jagged2 in myelinating Schwann cells (M-SC)
compared to non-myelinating cells (NM-SC). (b–f) Western blots show reduced endogenous
NICD after Ad-K20 infection of Schwann cells (b), increased endogenous NICD in P7 sciatic
nerves from Krox20–/– mice (c), reduced exogenous NICD after Ad-K20 infection at 1 (D1)
and 2 (D2) d in culture, with exposure to X-ray film too short to reveal endogenous NICD
(d), abolition of Ad-K20-mediated suppression of NICD expression by the proteosome
inhibitors MG132 and lactacystein (e), and elevated NICD in P0-cre+CALSL-NICD nerves at
birth (NB) but not at P7 (f). GAPDH/β-tubulin: loading control. (g) Enforced NICD expression
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reduces myelinating Schwann cells (arrows) in mutant nerves (quantification: Supplementary
Table 4). (h) Schwann cells with thin (arrowheads) or thick myelin sheaths (arrows) in P5
nerves with or without enforced NICD expression. Graph depicts the frequency of Schwann
cells at different myelin thickness and polynomial trend regression lines. The difference
between mutants and controls was significant (quantification: Supplementary Table 4). (i)
Ratio of myelinating to pro-myelinating Schwann cells (MS per PS); (j) frequency of Schwann
cells at a particular myelin thickness, in control and NICD-overexpressing P2 nerves with
normal (Mutant-K20+/+) or lower (Mutant-K20+/–) Krox20 levels. The mice with reduced
Krox20 had significantly reduced myelination (quantification: Supplementary Table 4).
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Figure 6.
Notch inactivation in Schwann cells leads to RBPJ-independent premature myelination. (a)
Frequency of Schwann cells with different myelin thickness in P5 sciatic nerves from P0-
cre+Notch1f/f mice. At each myelin thickness, the difference between mutants and controls was
significant (quantification: Supplementary Table 5). (b) Frequency of Schwann cells at
different myelin thickness in P5 sciatic nerves from P0–cre+RBPJf/f mice. At significant
(quantification: Supplementary Table 6). (c,d) Counts of periaxin+ (c) and P0+ cells (d) show
that enforced NICD expression inhibits cAMP-induced myelin protein expression equally in
control and RBPJnull Schwann cells. RBPJnull Schwann cells were obtained by treating
RBPJf/f cells with Cre adenovirus in vitro. (e,f) Counts of periaxin+ (e) and P0+ cells (f) show
that enforced NICD expression inhibits Krox20-induced myelin protein expression equally in
control and RBPJnull Schwann cells. Data: mean ± s.e.m., n = 3, *P < 0.01.
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Figure 7.
Notch promotes demyelination in injured nerves. (a) Notch activation accelerates
dedifferentiation of P5 myelinating Schwann cells in vitro. There are significantly fewer
periaxin+ (red) or P0+ (red) cells (arrows) in Ad-NICD-infected Schwann cells than in Ad-
GFP-infected cultures, 2 (D2) and 4 (D4) d after plating. Nuclei (blue): Hoechst dye.
Quantification is shown in right-hand panels. (b) Western blot shows elevation of NICD in the
distal stump of P60 nerves, 1 (D1) and 2 (D2) d after cut. (c,d) Schwann cell demyelination is
slower in the absence of RBPJ (P0-cre+RBPJf/ mice). (c) Electron micrographs of the distal
stump (2 mm from the cut site) of control and mutant adult nerves, 3 d after cut showing
Schwann cells with intact (arrows) or degenerating (arrowheads) myelin profiles. Right, counts
at 3 (D3) and 7 (D7) d after cut, 2 mm from cut site (n = 7, *P < 0.01). (d) MBP immunolabeling
of myelin (red) in the distal stump (2 mm from cut site) of control and mutant adult nerves, 3
d after cut. Right, measurement of total MBP+ areas at 2 and 7 mm from cut site (n = 6, *P <
0.01). (e) Western blot of NICD in uncut and 3 d cut P60 sciatic nerves from P0-cre+CALSL-
NICD mice. (f,g) Schwann cell demyelination is accelerated when NICD is overexpressed
(P0-cre+CALSL-NICD mice). For details, see c and d. Data: mean ± s.e.m., n = 3, *P < 0.01.
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Figure 8.
Notch activation induces extensive demyelination in vitro and in vivo. (a) Notch activation
results in extensive myelin breakdown in co-cultures of neurons and Schwann cells. After Ad-
GFP infection, MBP+ (red) myelin sheaths appear normal at low (arrows) and high
magnification (inset). After Ad-NICD infection, many myelin sheaths appear damaged
(arrowheads) with ovoids (inset). Non-infected cells have undamaged sheaths (asterisks).
Graph, percentage of Ad-GFP+ or Ad-NICD+ cells containing degenerating myelin, 3 (D3)
and 6 (D6) d after infection (n = 6, *P < 0.01). (b,c) Notch activation results in extensive myelin
breakdown in normal sciatic nerves. (b) Higher power view. After Ad-GFP infection, MBP+
myelin sheaths appear normal (arrows). After Ad-NICD infection, many myelin sheaths appear
damaged with ovoids (arrowheads). Non-infected cells have undamaged sheaths (asterisks).
Graph, percentage of Ad-GFP+ or Ad-NICD+ cells containing degenerating myelin (n = 10,
*P < 0.01). The low level of myelin degeneration in Ad-GFP+ fibers was similar to that in
uninfected MBP+ fibers, indicating that infection with control virus does not induce myelin
damage. Insets: single cells with intact (Ad-GFP) or degenerating (Ad-NICD) myelin. (c)
Lower power view. Most Ad-GFP+ cells contain MBP whereas most Ad-NICD+ cells do not,
indicating extensive myelin breakdown. Graph, MBP+ myelin area as a percentage of the total
GFP+ area (n = 10, *P < 0.01). Data: mean ± s.e.m.
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